{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/conjunctivitis-infective/","result":{"data":{"firstChapter":{"id":"fbd71ba7-3d3f-51a3-a9dd-4b52e0a56009","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 0ffbc241-7313-4a30-84b8-9d2aa7b339fa --><h1>Conjunctivitis - infective: Summary</h1><!-- end field 0ffbc241-7313-4a30-84b8-9d2aa7b339fa -->","htmlStringContent":"<!-- begin item 52c2691e-d718-4de4-8e20-874210222d0e --><!-- begin field 46d0bdf5-679a-40fc-96a0-1d71182c6170 --><ul><li>Infective conjunctivitis is inflammation of the conjunctiva due to viral, bacterial or parasitic infection.<ul><li>Viral conjunctivitis is the most common infectious conjunctivitis — the majority of cases are caused by adenoviruses.</li><li>The most common bacterial causes of conjunctivitis are <em>Streptococcus pneumoniae</em>, <em>Staphylococcus aureus</em> and <em>Haemophilus influenzae</em>.</li></ul></li><li>Hyperacute conjunctivitis is a rapidly developing severe conjunctivitis typically caused by infection with <em>Neisseria gonorrhoeae.</em></li><li>Ophthalmia neonatorum (ON) is conjunctivitis occurring within the first four weeks of life — it can be infectious or non-infectious.</li><li>Acute conjunctivitis is usually self-limiting and rarely causes loss of vision.<ul><li>Viral conjunctivitis usually resolves within 7 days. Epidemic keratoconjunctivitis (caused by adenoviruses) can lead to visual loss and light sensitivity.</li><li>Bacterial conjunctivitis typically resolves within 5 to 10 days. Contact lens wearers and immunocompromised people have the greatest risk of complications such as keratitis.</li><li>Most cases of ON are mild, however, untreated infection (for example with gonococcus, chlamydia, pseudomonas or herpes) can lead to serious complications including sight loss and mortality.</li></ul></li><li>In assessment of a person presenting with red eye, serious causes (such as acute glaucoma, keratitis, iritis and trauma) must be excluded.</li><li>It is difficult to differentiate viral and bacterial conjunctivitis clinically.</li><li>Characteristic clinical features of infective conjunctivitis include:<ul><li>Conjunctival erythema.</li><li>Discomfort which may be described as ‘grittiness’, ‘foreign body’ or ‘burning’ sensation.</li><li>Watering and discharge which may lead to transient blurring of vision — purulent or mucopurulent discharge may cause the lids to be stuck together on waking.</li></ul></li><li>Swabs should not be taken routinely but may be appropriate, if the person does not need to be referred to ophthalmology <em>and </em>has failed to respond to initial treatment.</li><li>Urgent referral to ophthalmology should be arranged if the person has:<ul><li>A red flag indicating a serious cause of red eye.</li><li>Ophthalmia neonatorum.</li><li>Suspected gonococcal or chlamydial conjunctivitis.</li><li>Possible herpes infection.</li><li>Suspected periorbital or orbital cellulitis.</li><li>Severe disease for example corneal ulceration, significant keratitis or presence of a pseudomembrane.</li><li>Had recent intraocular surgery.</li><li>Conjunctivitis associated with a severe systemic condition such as rheumatoid arthritis or is immunocompromised.</li><li>Corneal involvement associated with soft contact lens use.</li></ul></li><li>Discussion with or referral to ophthalmology is required if there is diagnostic uncertainty, lack of appropriate equipment to make a definitive diagnosis, or conjunctivitis is recurrent, persistent or due to <em>Molluscum contagiosum</em>. </li><li>Management of infective conjunctivitis in primary care involves:<ul><li>Reassuring the person that most cases are self-limiting.</li><li>Provision of patient information.</li><li>Advising self-care measures such as bathing/cleaning the eyelids, cool compresses, lubricating drops or artificial tears and avoidance of contact lenses.</li><li>Advising on appropriate infection control techniques.</li><li>Judicious use of topical antibiotics (such as chloramphenicol or fusidic acid second line) if bacterial conjunctivitis is suspected — a delayed treatment strategy may be appropriate.</li><li>Follow up and appropriate safety netting on red flag clinical features which may indicate the need for urgent review.</li></ul></li></ul><!-- end field 46d0bdf5-679a-40fc-96a0-1d71182c6170 --><!-- end item 52c2691e-d718-4de4-8e20-874210222d0e -->","topic":{"id":"245d0a83-e460-5cf6-bb9f-5b290f285eb6","topicId":"ed2c519f-023f-46a3-983a-117707073336","topicName":"Conjunctivitis - infective","slug":"conjunctivitis-infective","aliases":[],"chapters":[{"id":"fbd71ba7-3d3f-51a3-a9dd-4b52e0a56009","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"9e582b5b-cef7-5045-ac48-f2e16a0efce2","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"a6ad803b-b834-514c-a66c-51db50d9bbea","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"dc7859c4-e24d-53f8-9ae8-3ef60935541d","slug":"changes","fullItemName":"Changes"},{"id":"00dc0d59-2f79-5889-8444-4824089eb72e","slug":"update","fullItemName":"Update"}]},{"id":"ea2edf68-d8e0-5937-90ff-ee564bb02527","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"a34071e3-b1ed-5258-8e22-ae1bb85d5a3c","slug":"goals","fullItemName":"Goals"},{"id":"6a3dfcfe-0e37-5202-bef7-dd116ca18128","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9e9f3451-8747-5e06-91fa-c8523a7e68ba","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4883cd0c-a16c-59af-8b54-c6bd354f313d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7f7f5987-b50c-55c3-8e5d-666cbe7c6d48","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"84242960-0415-55ac-a1c2-8b5adaab83f4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f008541b-b7be-5af3-8714-e8146300ff54","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"f2e8a715-3f00-596d-8298-c250775f1fdb","slug":"definition","fullItemName":"Definition"},{"id":"dba4cb0f-b50c-512b-9e68-560be9ae7147","slug":"prevalence","fullItemName":"Prevalence"},{"id":"88ed8864-c0fc-510c-a4ec-438afedc7ced","slug":"causes","fullItemName":"Causes"},{"id":"3af23469-6316-5579-8439-affc8122afe4","slug":"complications","fullItemName":"Complications"},{"id":"f9f25145-3861-5ce7-b9aa-c90732e5def9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"7d7962ba-c1ee-5e78-9ec8-f1803268d57b","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"4368df5f-6b2c-5ac2-8d9d-42a96bc19760","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"08d4c01c-039f-5999-a16c-aba6061abcd8","slug":"assessment","fullItemName":"Assessment"},{"id":"abd6f420-3a9f-5aa4-9c9d-cb8731b2c750","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4f74d431-2e88-5b46-81f9-6459d459a761","slug":"management","fullItemName":"Management","subChapters":[{"id":"4ab0dfc8-5fff-5217-8bf6-5d0d5d842a1a","slug":"who-should-i-refer-to-ophthalmology","fullItemName":"Scenario: Who should I refer to ophthalmology?"},{"id":"b563c7fb-c61d-5f8d-9fea-cda5a3bc49ec","slug":"management-in-primary-care","fullItemName":"Scenario: Management in primary care"}]},{"id":"e288e22d-a343-590a-937c-923db47edf63","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"5c5a2718-f454-5220-81fd-c982d4420795","slug":"topical-chloramphenicol","fullItemName":"Topical chloramphenicol"},{"id":"00fd3462-346a-502b-8017-1e1435b2c834","slug":"topical-fusidic-acid","fullItemName":"Topical fusidic acid"}]},{"id":"71c6ce21-1821-52a1-9051-9a9312261074","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"f6c64841-06f4-529e-ab3c-b954aa2d45fa","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"518de4bc-ed53-5a8b-9936-01e04c351432","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"010e24d3-bdf1-5985-9e05-a9dd2c110ddb","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a1eeb52c-83bb-5f24-a172-735272c3a89e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fcd4d626-0c82-5190-bf8f-a45ab99540a1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d7fa1f43-6726-5ef3-8d4e-bec8cdc717e5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d2966af5-8ae1-5551-a8da-9ca043c0ca3e","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"245d0a83-e460-5cf6-bb9f-5b290f285eb6","topicId":"ed2c519f-023f-46a3-983a-117707073336","topicName":"Conjunctivitis - infective","slug":"conjunctivitis-infective","aliases":[],"topicSummary":"Infective conjunctivitis is inflammation of the conjunctiva due to viral, bacterial or parasitic infection.","lastRevised":"Last revised in April 2018","nextPlannedReviewBy":"2022-04-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-03","nextPlannedReviewByDisplay":"March 2022","specialities":[{"id":"485bdd1b-4437-5374-838e-f1f1db61a424","name":"Eyes","slug":"eyes"},{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"}],"chapters":[{"id":"fbd71ba7-3d3f-51a3-a9dd-4b52e0a56009","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"9e582b5b-cef7-5045-ac48-f2e16a0efce2","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"a6ad803b-b834-514c-a66c-51db50d9bbea","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"dc7859c4-e24d-53f8-9ae8-3ef60935541d","slug":"changes","fullItemName":"Changes"},{"id":"00dc0d59-2f79-5889-8444-4824089eb72e","slug":"update","fullItemName":"Update"}]},{"id":"ea2edf68-d8e0-5937-90ff-ee564bb02527","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"a34071e3-b1ed-5258-8e22-ae1bb85d5a3c","slug":"goals","fullItemName":"Goals"},{"id":"6a3dfcfe-0e37-5202-bef7-dd116ca18128","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9e9f3451-8747-5e06-91fa-c8523a7e68ba","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4883cd0c-a16c-59af-8b54-c6bd354f313d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7f7f5987-b50c-55c3-8e5d-666cbe7c6d48","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"84242960-0415-55ac-a1c2-8b5adaab83f4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f008541b-b7be-5af3-8714-e8146300ff54","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"f2e8a715-3f00-596d-8298-c250775f1fdb","slug":"definition","fullItemName":"Definition"},{"id":"dba4cb0f-b50c-512b-9e68-560be9ae7147","slug":"prevalence","fullItemName":"Prevalence"},{"id":"88ed8864-c0fc-510c-a4ec-438afedc7ced","slug":"causes","fullItemName":"Causes"},{"id":"3af23469-6316-5579-8439-affc8122afe4","slug":"complications","fullItemName":"Complications"},{"id":"f9f25145-3861-5ce7-b9aa-c90732e5def9","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"7d7962ba-c1ee-5e78-9ec8-f1803268d57b","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"4368df5f-6b2c-5ac2-8d9d-42a96bc19760","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"08d4c01c-039f-5999-a16c-aba6061abcd8","slug":"assessment","fullItemName":"Assessment"},{"id":"abd6f420-3a9f-5aa4-9c9d-cb8731b2c750","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4f74d431-2e88-5b46-81f9-6459d459a761","slug":"management","fullItemName":"Management","subChapters":[{"id":"4ab0dfc8-5fff-5217-8bf6-5d0d5d842a1a","slug":"who-should-i-refer-to-ophthalmology","fullItemName":"Scenario: Who should I refer to ophthalmology?"},{"id":"b563c7fb-c61d-5f8d-9fea-cda5a3bc49ec","slug":"management-in-primary-care","fullItemName":"Scenario: Management in primary care"}]},{"id":"e288e22d-a343-590a-937c-923db47edf63","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"5c5a2718-f454-5220-81fd-c982d4420795","slug":"topical-chloramphenicol","fullItemName":"Topical chloramphenicol"},{"id":"00fd3462-346a-502b-8017-1e1435b2c834","slug":"topical-fusidic-acid","fullItemName":"Topical fusidic acid"}]},{"id":"71c6ce21-1821-52a1-9051-9a9312261074","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"f6c64841-06f4-529e-ab3c-b954aa2d45fa","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"518de4bc-ed53-5a8b-9936-01e04c351432","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"010e24d3-bdf1-5985-9e05-a9dd2c110ddb","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a1eeb52c-83bb-5f24-a172-735272c3a89e","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fcd4d626-0c82-5190-bf8f-a45ab99540a1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"d7fa1f43-6726-5ef3-8d4e-bec8cdc717e5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d2966af5-8ae1-5551-a8da-9ca043c0ca3e","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"245d0a83-e460-5cf6-bb9f-5b290f285eb6"}},"staticQueryHashes":["3666801979"]}